Sweden approves medical ‘marijuana’. Following the lead of drug regulators in Germany, Denmark, the United Kingdom, Spain and four other European countries, Sweden’s Medical Products Agency (Läkemedelsverket) approved a cannabis-based mouth spray for the treatment of multiple sclerosis (MS) on Feb. 12.

Continue reading “Medical Marijuana for Multiple Sclerosis Patients”